Abstract
The US has backed a proposal to waive intellectual property relating to COVID measures – but global efforts need to go beyond vaccine patents.
| Original language | English |
|---|---|
| Specialist publication | The Conversation |
| Publication status | Published - 07 May 2021 |
| Externally published | Yes |
Access to Document
- TRIPS waiver: there’s more to the story than vaccine patents
Copyright 2021 The Authors. This is an open access article published under a Creative Commons Attribution-NoDerivatives License (https://creativecommons.org/licenses/by-nd/4.0/), which permits reproduction and redistribute in any medium, provided the author and source are cited and any subsequent modifications are not distributed.